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Abstract
Purpose—To detect and quantify choroidal neovascularization (CNV) in age-related macular
degeneration (AMD) patients using optical coherence tomography (OCT) angiography.
Design—Observational, cross-sectional study.
Participants—Five normal subjects and five neovascular AMD patients were included.
Methods—Five eyes with neovascular AMD and five normal age-matched controls were
scanned by a high-speed (100,000 A-scans/sec) 1050 nm wavelength swept-source OCT. The
macular angiography scan covered a 3×3 mm area and comprised 200×200×8 A-scans acquired in
3.5 sec. Flow was detected using the split-spectrum amplitude-decorrelation angiography
(SSADA) algorithm. Motion artifacts were removed by three dimensional (3D) orthogonal
registration and merging of 4 scans. The 3D angiography was segmented into 3 layers: inner retina
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(to show retinal vasculature), outer retina (to identify CNV), and choroid. En face maximum
projection was used to obtain 2D angiograms from the 3 layers. CNV area and flow index were
computed from the en face OCT angiogram of the outer retinal layer. Flow (decorrelation) and
structural data were combined in composite color angiograms for both en face and cross-sectional
views.
Main Outcome Measurements—CNV angiogram, CNV area, and CNV flow index.
Results—En face OCT angiograms of CNVs showed sizes and locations that were confirmed by
fluorescein angiography. OCT angiography provided more distinct vascular network patterns that
were less obscured by subretinal hemorrhage. The en face angiograms also showed areas of
reduced choroidal flow adjacent to the CNV in all cases and significantly reduced retinal flow in
one case. Cross-sectional angiograms were used to visualize CNV location relative to the retinal
pigment epithelium and Bruch’s layer and classify type I and type II CNV. A feeder vessel could
be identified in one case. Higher flow indexes were associated with larger CNV and type II CNV.
Conclusions—OCT angiography provides depth-resolved information and detailed images of
CNV in neovascular AMD. Quantitative information regarding CNV flow and area can be
obtained. Further studies are needed to assess the role of quantitative OCT angiography in the
evaluation and treatment of neovascular AMD.
Age-related macular degeneration (AMD) is the leading cause of blindness in older adults of
European descent.1 Neovascular AMD is an advanced form of macular degeneration that
historically has accounted for the majority of vision loss related to AMD.2 It is characterized
by the presence of choroidal neovascularization (CNV) consisting of abnormal blood vessels
that originate from the choroid. The vessels grow through Bruch’s membrane (BM) and
extend into the subretinal pigment epithelial (RPE) and/or subretinal space. CNV can result
in hemorrhage, fluid exudation, and fibrosis, resulting in photoreceptor damage and vision
loss.3 To diagnose neovascular AMD and evaluate the efficacy of treatment, determination
of the presence and precise location of the CNV lesion is essential.
Fluorescein angiography (FA) and indocyanine-green angiography (ICGA) are important
diagnostic tools used to detect and evaluate CNV in clinical practice. Leakage of dye in the
later frames of the angiogram is used to identify the presence of the CNV. Both FA and
ICGA require intravenous dye injection, which can result in nausea and, rarely,
anaphylaxis.4, 5
Optical coherence tomography (OCT) generates cross-sectional images by measuring the
echo time delay and magnitude of backscattered light.6 OCT has achieved micrometer-level
axial resolution in cross-sectional retinal imaging. The earliest retinal OCT imaging for
studying neovascular AMD was based on first-generation time-domain OCT technology,
which has limited speed and sensitivity.7–9 Spectral-domain OCT has greatly improved
speed and sensitivity and is able to detect small changes in the morphology of the retinal
layers and CNV activity in neovascular AMD.10, 11 More recently, swept-source OCT has
demonstrated improved ranging depth by using a rapidly tuned laser and a longer
wavelength (1050-nm spectral range) allowing for improved imaging beneath the RPE.12
Therefore, this novel OCT modality is under study and may allow for better visualization of
the CNV beneath the RPE.
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Structural OCT, using any technology, is only sensitive to backscattering light intensity and
cannot detect blood flow information. Due to this limitation, structural OCT cannot reliably
discriminate vascular tissue from the surrounding tissues; hence, the precise location and
activity of the CNV cannot be determined. Since 2007, several phase-based (e.g. Doppler
shift,13, 14 Doppler variance,15–17 and phase-variance18, 19) and intensity-based (e.g. speckle
variance20–22 and decorrelation23, 24) OCT angiography methods have been described for
three dimensional (3D) noninvasive vasculature mapping at the microcirculation level.
Miura et al25 and Hong et al26 recently demonstrated Doppler optical coherence
angiography for imaging 3D views of ocular vascular pathology in polypoidal choroidal
vasculopathy and exudative macular diseases, respectively.
Recently our group has developed the split-spectrum amplitude-decorrelation angiography
(SSADA) algorithm to improve signal-to-noise ratio of flow detection. This technique
enables OCT angiography within a practical image acquisition time (few seconds) using a
prototype that is only slightly faster than the newest generation of commercial systems. We
have performed the first clinical study for demonstrating ocular vascular disturbances in
glaucoma.27
In this study, we used OCT angiography with the SSADA algorithm23 to investigate CNV
associated with neovascular AMD. A descriptive case series of neovascular AMD is
presented to describe the usefulness of OCT angiography for visualizing 3D vascular
architecture and quantifying the blood flow within CNV.
METHODS
Study population
Patients were selected from clinical retina practices at the Casey Eye Institute. Patients
diagnosed with neovascular AMD underwent a comprehensive eye exam and routine
diagnostic evaluation consisting of color fundus photography, FA, and OCT (Spectralis;
Heidelberg Engineering, Heidelberg, Germany). Inclusion criteria were patients over the age
of 50 with the presence of drusen and treatment naïve CNV confirmed by fluorescein dye
leakage on angiogram and presence of one of the following on OCT: subretinal fluid,
intraretinal fluid, or subretinal pigment epithelial fluid. Exclusion criteria included subretinal
hemorrhage greater than 50% of the CNV lesion, visual acuity less than 20/200, and media
opacity interfering with OCT image quality, such as cataract.
OCT angiograms of normal subjects (aged 40 to 79) from a separate study, the “Functional
and Structural Optical Coherence Tomography for Glaucoma” study, were used as controls
in this study. Inclusion criteria from that study included: vision better than 20/40, no ocular
surgery other than previous cataract surgery, and no eye disease affecting vision. As
described below, 24 normal control subject’s images were used for normative retinal
thickness measurements and five control subjects (age > 60) underwent OCT angiography
processing.
Patients were enrolled after informed consent in accordance with an Institutional Review
Board (IRB)/Ethics Committee approved protocol at Oregon Health & Science University
Jia et al. Page 3
Ophthalmology. Author manuscript; available in PMC 2015 July 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
and in compliance with the Declaration of Helsinki. Once consent was obtained, patients
underwent scanning with the prototype OCT system.
OCT angiography
The prototype high speed swept-source OCT system was built by the Laser Medicine and
Medical Imaging Group at the Massachusetts Institute of Technology and followed the
configuration published by Potsaid et al. 23 The device operated at an axial scan speed of
100 kHz using a swept source cavity laser operating at 1050 nm with a tuning range of 100
nm. A resolution of 5.3 μm axially and 18 μm laterally at an imaging depth of 2.9 mm in
tissue was achieved. The ocular light power exposure was 1.9 mW, which was within the
American National Standards Institute (ANSI) safety limit.28
A 3×3-mm scanning area centered on the fovea was captured for blood flow measurements.
In the fast transverse scanning direction, 200 axial scans were sampled along a 3-mm region
to obtain a single B-scan. Eight consecutive B-scans (M-B frames) were captured at a fixed
position before proceeding to the next sampling location. A total of 200 locations along a 3-
mm region in the slow transverse direction were sampled to form a 3-D data cube. With a B-
scan frame rate of 455 frames per second, the 1,600 B-scans in each scan were acquired in
approximately 3.5 seconds. Four volumetric raster scans, including two horizontal priority
fast transverse (x-fast) scans and two vertical priority fast transverse (y-fast) scans, were
obtained consecutively in one session.
The SSADA algorithm was used to distinguish blood flow from static tissue as described in
detail in previous published paper and is briefly reviewed below. As seen in real-time OCT
structural images, the amplitude of the signal returning from nonstatic tissue varies rapidly
over time.29 By calculating the decorrelation of signal amplitude from consecutive B-scans,
a contrast between static and nonstatic tissue is created that allows for the visualization of
blood flow. However, decorrelation can also be generated by bulk (non-flow) eye motion.
The SSADA algorithm was developed to minimize bulk axial motion noise due to orbital
pulsation by splitting the spectrum and thereby lengthening the axial resolution element.
Additionally, the algorithm incorporated three steps to further remove motion artifact within
each angiography scan. First, using outlier analysis, the decorrelation frames with excessive
median decorrelation values (i.e., frames corrupted by saccadic and micro-saccadic eye
movements) were removed at each M-B scan position and the remaining individual frames
were averaged to obtain the final average decorrelation flow image. Second, if the number
of remaining individual frames is less than three for averaging, the average decorrelation
image at this location is replaced by the spatial neighbors. Third, the median decorrelation
(an estimate of bulk motion effect) was calculated for each average decorrelation frame and
then subtracted from it. This sets the decorrelation value for bulk tissue to around zero.
Physical flow phantom calibration experiments have been performed in our research group30
and by others.31 Decorrelation can be considered as a metric for measuring fluctuation in the
backscattered OCT signal amplitude (intensity) that does not depend on the average signal
level. To be specific, the blood flow results in fluctuation in the amplitude of OCT fringes
(speckle) as red blood cells move within a particular voxel. Hence the eight M-B frames
contain fluctuating values of OCT output intensities at any given voxel in the flow of blood,
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and the definition of decorrelation is constructed so that fluctuating intensities yield high
decorrelation values (approaching 1.0). Pixels in the M-B frames that represent static tissue
have constant intensities, and thus yield small decorrelation values (approaching 0). The
faster blood particles move across the laser beam, the higher is the decorrelation of the
received signals within a velocity range set by the scan parameters. In the other words,
decorrelation is approximately linear to flow velocity (the distance traveled by red blood
cells flowing across the light beam within a unit time).30, 31 However, beyond a saturation
velocity that is defined by the time interval between consecutive OCT M-B frames, the
decorrelation increases more slowly with velocity and eventually reaches an upper
boundary.31 This saturation velocity should be approximately 0.3 to 0.7 mm/sec according
to our30 and others’ physical phantom experiments,31 accounting for our wavelength of
1050 nm and inter-MB frame interval of 2 msec. The minimum velocity is approximately
0.02 mm/sec according to our phantom calibration. This is determined by the threshold
decorrelation value 0.09, which is two standard deviations above the mean decorrelation
value in the noise region, the central foveal avascular zone in normal eyes.
Motion artifacts were further corrected by applying an image registration algorithm that
registered 4 orthogonal raster scanned volumes.32 Motion correction was first performed on
the structural OCT data. The motion correction algorithm generated 3D displacement fields
that map A-scans from the input volumes into a common motion-corrected space. The same
displacement fields were applied to the decorrelation (flow) data to produce motion-
corrected flow data volumes. Flow data from 4 input volumes were weighted and merged,32
improving the signal-to-noise ratio in the flow signal, and reducing the flow measurement
variation due to local flow changes caused by the cardiac cycle.
To enhance visualization, the 3D angiogram was separately projected into en face views
(Fig. 1, available at www.aaojournal.org) in 3 layers using an automated algorithm.33, 34 The
inner retinal layer was defined from the internal limiting membrane (ILM) to the outer
boundary of the outer plexiform layer (OPL). Thus defined, the inner retina should contain
all of the normal retinal vasculature. The outer retinal layer was defined from the outer OPL
to the BM. Since the outer retina is normally avascular, any flow in this layer could be
interpreted as CNV. The choroidal layer was defined as below BM. All these boundaries
were identified through the analysis of the reflectance and reflectance-gradient profiles in
depth. Clinician’s interpretation and manual identification of BM and the OPL was
necessary when pathologies such as pigment epithelial detachment (PED) and intraretinal
fluid obscured the outer retinal landmarks (AMD case # 3). Separate en face images of the
inner retina, outer retina, and choroid were presented in a sepia color scale. A composite
view was also developed, where each layer was assigned a different color (Figs. 1–4; Figs 1
and 4 available at www.aaojournal.org) to aid with visualization as follows. The inner retina
contained normal retinal circulation and was coded purple. The outer retinal layer contained
any potential CNV and was coded yellow. The choroid layer was coded red.
Structural OCT features were added to OCT angiography with composite en face view and
color coding demonstrating subretinal fluid (dark blue) and intraretinal cysts (light blue).
These two types of fluid are both detected using a level-set segmentation method 35 due to
the fact that the reflectance of cysts and sub-retinal fluid is significantly lower than the
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surrounding tissue in retina. Based on the difference between their position, shape, and size,
these fluid regions can be classified as the intraretinal or the subretinal. Additionally, the
variation in retinal thickness was calculated, normalized by the normal retina thickness
range, and presented as a retinal thickness deviation map. For the purpose of this pilot study,
an estimate of normal retinal thickness with the prototype OCT was obtained from 24
normal eyes from 24 subjects.
A method was also developed to remove flow projection artifacts. The cross-sectional
angiogram (Fig. 1B, available at www.aaojournal.org) showed flow projection artifacts on
the photoreceptor inner segment/outer segment (IS/OS) boundary and RPE. The projection
artifacts were due to fluctuating shadows cast by flowing blood in large inner retinal vessels
that cause variation in the reflected signal in deeper layers. The signal variation was detected
as a decorrelation and could not be differentiated from true flow on its own. However, these
artifacts were removed from under the flow pixels in the inner retina. To remove flow
projection artifacts from superficial retinal blood vessels to outer retina, we first generated a
binary large inner retinal vessel map by applying a 30×30 pixel Gaussian filter. This filter
removed small inner retinal vessels and masked the outer retina flow map, thus enabling the
subtraction of large vessel projections. A binary outer retinal flow map was then generated
by applying a 10×10 pixel Gaussian filter to remove remaining noise and mask the outer
retinal flow map again to obtain a clean map. After these artifacts were removed by the
mask subtraction operation, there were no longer any flow artifacts in the normally
avascular outer retina, as shown in the cross-sectional color angiogram (Fig. 1C) and the en
face angiogram of the outer retina (Fig. 1E).
To quantify the blood flow within the CNV, the CNV area and flow index were calculated
from the 2D maximum projection outer retina CNV angiogram. The CNV area was
calculated by multiplying the number of pixels (for which the decorrelation value was above
that of the background) and the pixel size. The CNV flow index was the average
decorrelation value in the CNV region, given by,
where D is the decorrelation value acquired by SSADA. V is 1 when decorrelation value
was above background; otherwise, V is 0. Flow index is a dimensionless parameter between
0 and 1 that is proportional to the density of blood vessels (fractional area occupied by
vessels) and the velocity of blood flow in the CNV region.
RESULTS
OCT angiograms of five neovascular AMD eyes were compared with five normal eyes. The
CNV area and flow index was calculated from all neovascular AMD cases. None of the five
normal cases had flow detected in outer retina and CNV area and flow index were zero. A
representative normal control case and three of the neovascular AMD cases are presented.
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Normal control case
A 69-year old female with no ocular disease served as a control case (Fig. 1, available at
www.aaojournal.org). The inner retinal angiogram (Fig. 1D) showed the normal retinal
circulation with a small foveal avascular zone of approximately 0.6 mm in diameter. The
absence of any flow in the outer retinal layer (Fig. 1E) allowed easy detection of CNV in the
cases to be shown later. The absence of blood flow in the outer retina was noted in all 5
normal control participants. The flow in the inner choroid was nearly confluent (Fig. 1C, 1F)
and masked the vascular patterns in the outer choroid and sclera in the en face angiogram
(Fig. 1F). The signal voids in the larger vessels in the outer choroid were due to the high
flow velocity (Fig. 1A–C).
AMD case 1
A 65-year-old female noted vision loss in her right eye for one month. Visual acuity
measured 20/100 in the right eye. Fundus photography (Fig. 2A) showed drusen and a small
subretinal hemorrhage associated with a gray subretinal lesion just nasal to the fovea. FA
(Fig. 2B, C) revealed early hyperfluorescence with late leakage consistent with classic CNV.
OCT angiography showed a normal retinal circulation (Fig. 2D, H). The outer retinal OCT
angiogram (Fig. 2E, H) showed high flow in a CNV network in a pattern strikingly similar
to the early phase of FA. The cross-sectional color OCT angiogram (Fig. 2G) showed the
CNV to be underneath the RPE and above BM, indicating type I CNV. The subretinal
hemorrhage above the CNV (Fig. 2G) did not seem to obscure the CNV on either the FA or
OCT angiograms (Fig. 2E, H).
The en face OCT angiogram of the choroid (Fig. 2F) showed loss of choriocapillaris
revealing deeper, larger choroidal vessels (compare to normal choroid in Fig. 1F). An area
inferotemporal to the CNV had particularly low flow in both the choriocapillaris and deeper
choroid (Fig. 2F, green outline). This low flow choroidal region had high OCT reflectance
signal (Fig. 2G, green arrow), therefore the reduced flow was not caused by a shadow
artifact.
The composite en face OCT angiogram (Fig. 2H) showed that the CNV was at the
superonasal edge of the fovea avascular zone (FAZ) and that subretinal fluid was
accumulated next to the CNV. The OCT retinal thickness map (Fig. 2I) showed retinal
thickening over the CNV that was primarily due to the inclusion of subretinal hemorrhage
(Fig. 2G) in the retinal thickness measurement, and an element of retinal edema inferior to
the CNV. These en face OCT views combined angiographic (CNV size, location, flow) and
structural information (fluid, edema) that would be useful for clinical management.
AMD case 2
A 76-year-old female noticed vision loss in her left eye for one week. Visual acuity
measured 20/30, and fundus examination (Fig. 3A) of the left eye revealed drusen and a
gray/green lesion in the temporal macula with associated subretinal hemorrhage. Early
frames of the FA revealed a hyperfluorescent vascular network in the temporal macula with
late leakage (Fig. 3B, C).
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OCT angiography showed details of the CNV structure, with a central feeder vessel from
which radiated thick core vessels ending in fine vascular fronds (Fig. 3E, J; Video 1,
available at www.aaojournal.org). Both the FA and OCT angiogram show an identical CNV
location, with slight notching at the superonasal edge due to shadowing from the small patch
of subretinal hemorrhage. Cross-sectional OCT angiography (Figs. 3 G, H; Video 2,
available at www.aaojournal.org) revealed that most of the CNV flow was above the RPE,
indicating a predominantly type II CNV. Due to the flow projection artifact, there appeared
to be flow in the RPE below the CNV.
The en face OCT angiogram of the choroid (Fig. 3F) showed patchy loss of choriocapillaris,
which allowed visualization of intermediate-to-large deeper choroidal vessels that were not
visible in the healthy control (Fig. 1F). There were focal regions under and adjacent to the
CNV where there was greatly reduced flow in both the choriocapillaris and deeper choroid
(Fig. 3F–H). Although some of this might be explained by shadowing under the CNV, the
hypoperfused choroid adjacent to the CNV had normal OCT reflectance (Fig. 3I),
suggesting that the loss of choroidal flow was real rather than an artifact.
The composite en face OCT angiogram showed that the CNV was at the superotemporal
edge of the FAZ. Subretinal fluid accumulated superonasal to the CNV, and intraretinal
cystic fluid accumulated above the CNV. Retinal thickening shown on the relative thickness
map (Fig. 3K) correlated with the intraretinal fluid accumulation.
AMD case 3
An 88-year-old female noted vision loss in her right eye for several months (Fig. 4, available
at www.aaojournal.org). Visual acuity in the right eye was 20/200. Fundus photography
(Fig. 4A) demonstrated chronic geographic atrophy in the superior nasal macula with new
subretinal hemorrhage and an associated RPE tear temporal to the geographic atrophy.
Fluorescein angiography showed late leakage consistent with a CNV (Fig. 4B, C). However,
the location of the CNV was unclear due to blocking from the subretinal hemorrhage.
Hypofluorescence from the scrolled RPE and hyperfluorescence-associated geographic
atrophy were evident.
The inner retinal angiogram in this case (Fig. 4D) showed an apparent reduction in inner
retinal blood flow that may have indicated retinal atrophy. This patient had difficulty with
fixation and slight motion artifacts (horizontal and vertical dark lines) were evident despite
the use of 3D registration software.
OCT angiography of the outer retina (Fig. 4E–H) showed a distinct CNV adjacent to the
subretinal hemorrhage. The nasal edge of the CNV was blocked from view where the
subretinal hemorrhage was thicker and cast a shadow. The cross-sectional OCT angiogram
(Fig. 4G) revealed high CNV flow at the edge of the RPE tear. Flow was detected both
above and below the RPE, indicating a combined type I and type II lesion. Besides the CNV,
there was also accumulation of a large amount of stationary (nonvascular) material under the
PED.
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The en face choroidal angiogram (Fig. 4F) showed reduced signal both under the PED and
in the area of geographic atrophy. The area under the PED showed low reflectance on OCT
cross-section (Fig. 4G) and no vascular pattern on the en face OCT angiogram (Fig. 4F).
This suggested that the reduced choroidal flow was a shadow artifact associated with the
PED and scrolled RPE (Fig. 4F). A similar area of blocked fluorescence was present on FA
(Fig. 4B, C). In contrast, the area of geographic atrophy showed distinct large, deep
choroidal vessels and loss of choriocapillaris.
The composite en face OCT angiogram (Fig. 4H) showed the CNV to be inferior to the FAZ
and associated with a surrounding accumulation of both intraretinal and subretinal fluids.
There was retinal thinning over the CNV (Fig. 4I), possibly due to focal compression from
the highly elevated CNV and RPE tear (Fig. 4G). There was gross retinal thickening around
the CNV (Fig. 4I) associated with fluid accumulation (Fig. 4H). The heavy accumulation of
intraretinal fluid and reduced retinal blood flow visualized on the en face composite OCT
angiogram may explain the poor visual acuity.
Evaluation of choroidal flow in AMD
OCT angiography of the choroid showed reduced inner choroidal flow in all five AMD
cases compared to the control cases that allowed visualization of larger and deeper choroidal
vessels. Conventional FA and structural OCT did not reveal geographic atrophy or other
abnormalities that accounted for the choriocapillaris atrophy in most of these areas. In
addition, focal areas of decreased flow in both superficial and deeper choroidal vessels were
associated with CNV in all of the AMD cases, except for Case 3, where the presence of a
focal choroidal flow defect could not be determined because of shadowing by the scrolled
RPE (Fig. 4F).
Quantification of the area and flow index of CNV
Quantitative measurements of CNV area and flow index were summarized in Table 1. High
flow index indicated active blood flow within the CNV. Higher flow was detected with
larger CNVs and those that were type II compared to type I and combined CNVs.
DISCUSSION
Structural OCT has become an indispensable tool in the management of AMD. It allows the
clinician to assess fluid exudation from CNV as manifested by intraretinal cysts, retinal
thickening, and subretinal fluid accumulation. It identifies the alterations in normal retinal
anatomy that are associated with visual potential. However, structural OCT images cannot
identify the CNV structure itself. Although structural OCT can identify abnormal tissue
above or below the RPE that might be CNV, positive identification is not possible because
CNV tissue has similar reflectivity as drusenoid material, hemorrhage, RPE, and choroid.36
Therefore FA or ICGA are still needed in the initial diagnosis of neovascular AMD. Because
FA and ICGA require intravenous dye injection, nausea and vomiting are common adverse
reactions, and serious anaphylactic reactions are possible.4, 5 Therefore it is highly desirable
to develop a noninvasive method of imaging CNV. Unfortunately, 2D flow imaging
technologies such as scanning laser Doppler flowmetry,37 laser speckle photography,38 and
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laser speckle flowgraphy39 are not able to clearly distinguish flow in the CNV from the
underlying choroidal circulation. A 3D flow imaging technology such as OCT angiography
is needed.
Hong et al. used Doppler optical angiography to image CNV associated with neovascular
AMD, polypoidal vasculopathy, and myopic macular degeneration.25, 26 However, in this
pioneering work, it remained difficult to distinguish the CNV from the retinal and choroidal
vasculature in the en face projection views, and quantification of CNV was not attempted. In
this paper, we reported improvements in OCT angiography segmentation, visualization, and
quantification to provide comprehensive information that a clinician could use to assess and
manage CNV.
Here we investigated the capability of OCT angiography for imaging and quantifying CNV
in neovascular AMD patients. A high-speed swept-source OCT system at 1050 nm
wavelength provided for deeper penetration compared to standard 830 nm OCT and
improved imaging below the RPE. We used a new type of OCT angiography algorithm
called SSADA, which is based on detecting the reflectance amplitude (or intensity) variation
over time due to flow in vascular volumes. Neither amplitude- nor intensity-based OCT
angiography require accurate determination of background tissue phase variation due to
motion, and are therefore more robust than Doppler or phase-based OCT angiography.31
The SSADA algorithm improves on the standard amplitude or intensity-based
algorithms20, 22, 23, 40 by enhancing signal and suppressing noise through spectral splitting
of the OCT images.23
We segmented the 3D angiograms into 3 separate vascular layers. Taking advantage of the
fact that the outer retinal layer is normally devoid of blood flow, we were able to provide
clean en face visualization of the CNV structure. By optimizing the choice of color and
transparency, we were able to highlight the CNV relative to the inner retinal vascular pattern
in a composite en face angiogram. Evidence of CNV activity, such as subretinal fluid and
intraretinal cysts, was also incorporated into the composite view. This may be very helpful
to the clinician in the rapid assessment of CNV and its response to treatment. Since both
functional (blood flow) and structural (fluid accumulations) information are taken from a
single OCT scan, they are naturally perfectly registered. This is simpler and potentially
much faster and robust than combining structural OCT with FA or ICG taken from separate
instruments.
Using these new imaging, processing, and display technologies, we successfully identified
blood flow in CNVs in five treatment-naïve neovascular AMD cases. The SSADA flow
signal was very useful in distinguishing CNV from the surrounding outer retinal tissue,
hemorrhage, RPE, BM, and non-flow material under PEDs. Using color OCT cross-
sectional angiograms that combined flow and structural information, we were able to
determine the position of the CNV relative to the RPE and BM, and thereby classify the
CNV as type I, type II, or combined type. In one case, a feeder vessel between the choroid
and CNV was successfully visualized (Fig 3), which is rarely possible using FA and ICGA.
The position of the CNV on en face OCT images was confirmed by FA in all 5 cases.
Compared to FA, en face OCT angiograms show a more distinct CNV vascular network
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pattern that is less obscured by overlying subretinal hemorrhage, as one would expect due to
the longer wavelength employed by OCT.
Our pilot study also demonstrated, for the first time, quantitative assessments of CNV area
and flow index that is proportional to average avascular density and also flow velocity on
the capillary scale. In our small sample of five patients, we noticed higher CNV flow was
associated with larger CNV area and type II classification, but larger studies are needed to
confirm these associations. Measurements of CNV area and flow index provide new
information on CNV activity that may be early indicators of treatment response or relapse.
Further studies are needed to assess the clinical utility of these new image-derived metrics.
In addition to providing depth-resolved information of CNV, OCT angiography may provide
further insight into choroidal flow and AMD pathogenesis. En face choroidal angiograms of
the control cases showed confluent signals from choriocapillaris that obscured visualization
of larger, deeper choroidal vessels. In all five of the AMD cases, deep choroidal vessels
were more apparent and we suspect this is due to loss of choriocapillaris associated with
AMD. Some regions of choriocapillaris loss could be attributed to geographic atrophy (Fig.
4F) or due to shadowing from thick hemorrhage, CNV, or PED. However, there were also
areas of choriocapillaris loss that could not be attributed to geographic atrophy or shadowing
effect. Particularly notable among these areas were focal regions adjacent to CNV where
there was total absence of choriocapillaris with loss of both inner and deeper choroidal
vessels. We suspect these focal areas of choroidal hypoperfusion with possible outer retinal
ischemia may have a role in CNV pathogenesis. Several studies41,42 have identified
abnormalities in choroidal flow associated with CNV in AMD. McLeod and Lutty provided
histologic evidence of choriocapillaris atrophy in the vicinity of CNV.43 Although ICGA
has often been used to assess the choroidal circulation in CNV, the noninvasive nature of
OCT angiography may allow for more frequent assessments of choroidal changes in large,
longitudinal clinical studies to identify possible precursors to neovascular AMD
development.
Besides its noninvasive nature, OCT angiography has several compelling characteristics that
make it a promising modality for clinical use. OCT angiography can be acquired in a few
seconds, compared to several minutes for FA. The 3D imaging allows for depth resolution
of pathology and separation of individual vascular layers for evaluation. The OCT
angiography scan pattern and SSADA processing can be implemented on spectral-domain or
swept-source OCT systems without any special hardware modification.
In addition, the new SSADA algorithm allows for a relatively quantitative reliable flow
meaurements. By using decorrelation instead of variance of reflected signal to measure flow,
the measurement is largely independent of OCT signal strength level over a wide range.27
This is important because previous techniques such as the laser Doppler flowmetry (e.g.
Heidelberg Retinal Flowmeter) could not reliably compare flow values between individuals
due to the effect of signal strength on the measurements.44–48 In SSADA algorithm,
background bulk tissue motion was measured and removed at three different levels (see
METHODS). This was highly effective as demonstrated by the absence of any retinal flow
in normal subjects in the foveal avascular zone and in the outer retina in general. Thus the
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flow index is a relatively clean measure of blood flow. Another strength of SSADA is that
the decorrelation measures flow in both transverse and axial directions with nearly equal
sensitivity. This omnidirectional nature has been verified experimentally.30 This is different
from Dopper shift-based techniques,13, 14 which is much more sensitive to axial flow than
transverse flow. Chorioretinal vessels are largely transverse to the OCT probe beam, but
vary over a range of incidence angles. Doppler shift-based flow measurements are biased by
incidence angle, unless the Doppler angle is explicitly measured,49, 50 or otherwise
accounted for.51–54 The decorrelation value measured by SSADA is independent of incident
angle and therefore a more robust measurement of flow. Certainly, a limitation of
decorrelation and its derived flow indexes are that they are in arbitrary units and are affected
by imaging parameters such as the time interval between consecutive B-scan (cross-
sectional) image frames, split-spectral bandwidth and the wavelength. The spot diameter
may also have an effect. However, because these parameters are fixed for OCT systems or
could be controlled by software, it is possible to keep these parameters constant and make
meaningful measurement that could be compared between individuals and between visits.
There are several limitations to OCT angiography. High scanning speed is needed to provide
sufficient cross-sectional frame rate to overcome background eye motion. Therefore the
current generation of commercial OCT systems at 20–40 kHz speed may be insufficient.
The next generation of OCT systems, running at 70–100 kHz, is likely required. In the
present study, the 100 kHz OCT prototype image provided a small 3-mm square field of
view. We have recently improved the scan and processing software to provide a 4-mm field
of view. However, a larger field of view will require an even higher speed. Because
laboratory OCT prototypes of multi-MHz speed have already been reported,55–57 we believe
the speed and scan size area limitations will be solved as commercial implementation
catches up to laboratory technology. FA provides dynamic information currently not
available with OCT angiography such as transit time of fluorescein dye to travel to the eye.
Additionally, changes in patterns of fluorescence over time (staining, leakage, pooling) are
used for identifying and distinguishing various pathological conditions as well as assessment
of disease activity, such as CNV. Flow detected on OCT angiography alone will not account
for all of this information. However, it is possible in the future that combining information
from OCT such as: fluid identified with structural OCT, segmentation of individual
structures such as RPE (providing information analogous to staining), and angiographic
OCT flow information; may allow for more comprehensive clinical picture with OCT
technology.
This pilot study demonstrated the ability of OCT angiography, with the SSADA algorithm,
to image CNV and provide quantitative data in its natural state. Additional studies
evaluating change in CNV structure, CNV area, and flow index while under treatment with
anti-vascular endothelial growth factor therapy are underway. We hope future investigations
of quantitative OCT angiography will aid with evaluation and management of neovascular
AMD.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Healthy control case. (A) Cross-sectional optical coherence tomography (OCT) reflectance
image (conventional OCT B-scan). (B) Cross-sectional OCT angiography. Arrows point to
locations where flows in inner retinal vessels are projected onto bright photoreceptor and
retinal pigment epithelium layers. (C) Cross-sectional color OCT angiogram. The internal
limiting membrane (ILM) and outer plexiform layer (OPL) and Bruch’s membrane (BM) are
the boundaries separating inner retinal, outer retinal, and choroidal circulations. (D) En face
angiogram of the inner retina. The dashed line indicates the cross-sections shown in A–C
above. (E) En face angiogram of the outer retina. (F) En face angiogram of the choroid. En
face angiograms were produced by maximum flow projections within segmented layers and
span a 3×3 mm area. Higher decorrelation value corresponds to higher blood flow velocity.
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Figure 2.
Age-related macular degeneration case 1: type I choroidal neovascularization (CNV). (A)
Color fundus photograph showing subretinal hemorrhage. Red square outlines the area
shown on angiograms below. (B) Early phase fluorescein angiogram (FA). (C) Late phase
FA. (D) En face optical coherence tomography (OCT) angiogram of the inner retina. (E) En
face angiogram of the outer retina showing the CNV. The yellow dashed lines indicate the
position of OCT cross-section shown in Panel G. Yellow arrows indicate the superior to
inferior direction. (F) En face angiogram of the choroid showing patchy flow directly under
the CNV (blue dotted outline) and an adjacent area of reduced flow (green dotted outline).
(G) Cross-sectional color OCT angiogram showing the CNV (yellow) was predominantly
under the retinal pigment epithelium (RPE). The blue arrow shows the location of the
subretinal fluid. The green arrow corresponds to the green dashed outline in Panel F
showing a focal region of reduced choroidal flow adjacent to the CNV. S: superior; I:
inferior. (H) Composite en face OCT angiograms showing most subretinal fluid (dark blue)
inferior to the CNV. (I) Retinal thickness deviation map showing retinal thickening over the
CNV.
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Figure 3.
Age-related macular degeneration case 2: type II choroidal neovascularization (CNV). (A)
Fundus photography showing subretinal hemorrhage. The red square outlines the area
shown on angiograms below. (B) Early phase fluorescein angiogram (FA). (C) Late phase
FA. (D) En face optical coherence tomography (OCT) angiogram of the inner retina. (E) En
face OCT angiogram of the outer retina showing the CNV. The yellow and green dashed
lines indicate the position of OCT cross-section shown in Panels G, H and I. (F) En face
angiogram of the choroid showing the patchy reduced flow directly under the CNV (blue
dotted outline) and an adjacent area of reduced flow (green dotted outline). (G) Vertical
cross-sectional color OCT angiogram showing the CNV (yellow) was predominantly above
the retinal pigment epithelium (RPE). The green solid arrow corresponds to the green dotted
outline in F showing a focal region of reduced choroidal flow inferonasal to the CNV. The
green hollow arrow points out a high choroidal flow signal superior to the CNV. (H)
Horizontal cross-sectional color OCT angiogram showing the feeder vessel (yellow dotted
circle) that corresponds to the white arrows in Panels E and F. Also note cystic intraretinal
fluid above the CNV. (I) Horizontal cross-sectional OCT reflectance image showing the
feeder vessel seen as a flow void. (J) Composite en face OCT angiogram showing subretinal
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fluid (dark blue) at the superonasal corner and intraretinal fluid (light blue) over the CNV.
(K) Retinal thickness deviation map showing thickening over the CNV. Fly through movies
of 3D color OCT angiograms are available as a supplement (Video 1 and 2).
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Figure 4.
Age-related macular degeneration case 3: combined type I and type II choroidal
neovascularization (CNV). (A) Fundus photography showing subretinal hemorrhage, retinal
pigment epithelium (RPE) tear, and geographic atrophy (blue dashed outline). Red square
outlines area shown on angiograms below. (B) Early phase fluorescein angiogram (FA). (C)
Late phase FA. (D) En face optical coherence tomography (OCT) angiogram of the inner
retina. (E) En face angiograms of the outer retina showing the CNV. The yellow dashed
lines indicate the position of OCT cross-section shown in Panel G. (F) En face angiogram of
the choroid showing diffuse reduction of flow signal under the pigment epithelial
detachment and choriocapillaris defect in the area of geographic atrophy (blue dashed
outline). (G) Cross-sectional color OCT angiogram showing the CNV both above and below
the RPE. The subretinal hemorrhage was over the CNV and overshadowed the CNV at its
nasal edge. (H) Composite en face OCT angiograms. (I) Retinal thickness deviation map
showing thinning over the CNV and thickening around it.
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Table 1
Summary of CNV types, CNV area and CNV flow index of five scanned AMD cases
AMD Case # Sex/Age CNV Types CNV Area (mm2) CNV Flow Index (a.u.)
1 F/65 type I 0.29 0.127
2 F/76 type II 2.18 0.146
3 F/88 combined 0.13 0.130
4 F/85 type II 0.89 0.148
5 M/70 combined 0.05 0.120
AMD: Age-related macular degeneration; CNV: Choroidal neovascularization; F: Female; M: Male; a.u.: arbitrary unit
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